BridgeMD
Tests treatment safety and results for Postoperative Pain
Official title Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery
ClinicalTrials.gov ID: NCT06320041
What this study is testing
What is Low dose oxelidine group?
Low dose oxelidine group is an investigational medicine, given as an once-daily infusion into a vein, being studied as a potential treatment for postoperative pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial] is to further explore the effectiveness and safety of oxelidine in the treatment of moderate to severe acute pain after orthopedic surgery. The main question it aims to answer is: Pain management after orthopaedic surgery provides more effective and safe drug options, provides new options for clinical treatment, and provides a scientific basis for clinical practice.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100
You may be able to join if
- elective orthopedic surgery under general anesthesia.
- The patient can communicate normally and has the correct expression of pain
You likely can't join if
- Patients with advanced tumor
- Other acute and chronic pain conditions are present
- Severely obese (30 kg/m2)
- Pregnant or lactating women
- Allergy to opioids
- Sleep apnea syndrome
See the full eligibility criteria
- elective orthopedic surgery under general anesthesia.
- The patient can communicate normally and has the correct expression of pain
- Patients with advanced tumor
- Other acute and chronic pain conditions are present
- Severely obese (30 kg/m2)
- Pregnant or lactating women
- Allergy to opioids
- Sleep apnea syndrome
- Long-term opioid treatment
- Patients with mental and nervous system diseases, gastrointestinal obstruction, chronic obstructive pulmonary disease or pulmonary heart disease, cardiovascular disease
- Abnormal liver function during screening
- Abnormal renal function during screening
The study team makes the final eligibility decision.
Where it's taking place
- Yiwu, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Yiwu, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.